1,256
Views
0
CrossRef citations to date
0
Altmetric
Assessment Procedures

Validation of the Swedish version of PROMIS-29v2 and FACIT-Dyspnea Index in patients with systemic sclerosis

ORCID Icon, ORCID Icon & ORCID Icon
Pages 2517-2525 | Received 17 Mar 2020, Accepted 25 Jun 2022, Published online: 21 Sep 2022

References

  • Steen VD, Medsger TA Jr. Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum. 2000;43(11):2437–2444.
  • Johnson SR, Glaman DD, Schentag CT, et al. Quality of life and functional status in systemic sclerosis compared to other rheumatic diseases. J Rheumatol. 2006;33(6):1117–1122.
  • Hudson M, Steele R, Canadian Scleroderma Research Group (CSRG), et al. Update on indices of disease activity in systemic sclerosis. Semin Arthritis Rheum. 2007;37(2):93–98.
  • Jaeger VK, Distler O, Maurer B, et al. Functional disability and its predictors in systemic sclerosis: a study from the DeSScipher project within the EUSTAR group. Rheumatology. 2018;57(3):441–450.
  • Boyce MB, Browne JP. Does providing feedback on patient-reported outcomes to healthcare professionals result in better outcomes for patients? A systematic review. Qual Life Res. 2013;22(9):2265–2278.
  • Cella D, Yount S, Rothrock N, et al. The Patient-Reported Outcomes Measurement Information System (PROMIS): progress of an NIH roadmap cooperative group during its first two years. Med Care. 2007;45(5 Suppl. 1):S3–S11.
  • Cella D, Riley W, Stone A, et al. The Patient-Reported Outcomes Measurement Information System (PROMIS) developed and tested its first wave of adult self-reported health outcome item banks: 2005–2008. J Clin Epidemiol. 2010;63(11):1179–1194.
  • Yount SE, Choi SW, Victorson D, et al. Brief, valid measures of dyspnea and related functional limitations in chronic obstructive pulmonary disease (COPD). Value Health. 2011;14(2):307–315.
  • Hinchcliff M, Beaumont JL, Thavarajah K, et al. Validity of two new patient-reported outcome measures in systemic sclerosis: Patient-Reported Outcomes Measurement Information System 29-item health profile and functional assessment of chronic illness therapy-dyspnea short form. Arthritis Care Res. 2011;63(11):1620–1628.
  • Kwakkenbos L, Thombs BD, Khanna D, et al. Performance of the Patient-Reported Outcomes Measurement Information System-29 in scleroderma: a scleroderma patient-centered intervention network cohort study. Rheumatology. 2017;56(8):1302–1311.
  • Morrisroe K, Stevens W, Huq M, et al. Validity of the PROMIS-29 in a large Australian cohort of patients with systemic sclerosis. J Scleroderma Relat Disord. 2017;2(3):188–195.
  • Fisher CJ, Namas R, Seelman D, et al. Reliability, construct validity and responsiveness to change of the PROMIS-29 in systemic sclerosis-associated interstitial lung disease. Clin Exp Rheumatol. 2019;37 Suppl. 119(4):49–56.
  • Eremenco SL, Cella D, Arnold BJ. A comprehensive method for the translation and cross-cultural validation of health status questionnaires. Eval Health Prof. 2005;28(2):212–232.
  • van den Hoogen F, Khanna D, Fransen J, et al. 2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 2013;65(11):2737–2747.
  • Orwelius L, Nilsson M, Nilsson E, et al. The Swedish RAND-36 health survey – reliability and responsiveness assessed in patient populations using Svensson’s method for paired ordinal data. J Patient Rep Outcomes. 2017;2(1):4.
  • Fletcher CM, Clifton M, Fairbairn AS, et al. Standardized questionnaires on respiratory symptoms. Br Med J. 1960;2(5213):1665.
  • Steen VD, Medsger TA Jr. The value of the Health Assessment Questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time. Arthritis Rheum. 1997;40(11):1984–1991.
  • LeRoy EC, Black C, Fleischmajer R, et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol. 1988;15(2):202–205.
  • Wuttge DM, Carlsen AL, Teku G, et al. Specific autoantibody profiles and disease subgroups correlate with circulating micro-RNA in systemic sclerosis. Rheumatology. 2015;54(11):2100–2107.
  • Medsger TA Jr., Silman AJ, Steen VD, et al. A disease severity scale for systemic sclerosis: development and testing. J Rheumatol. 1999;26(10):2159–2167.
  • Clements PJ, Lachenbruch PA, Seibold JR, et al. Skin thickness score in systemic sclerosis: an assessment of interobserver variability in 3 independent studies. J Rheumatol. 1993;20(11):1892–1896.
  • Sandqvist G, Eklund M. Hand mobility in scleroderma (HAMIS) test: the reliability of a novel hand function test. Arthritis Care Res. 2000;13(6):369–374.
  • Akesson A, Gustafson T, Wollheim F, et al. Esophageal dysfunction and radionuclide transit in progressive systemic sclerosis. Scand J Rheumatol. 1987;16(4):291–299.
  • Hays RD, Spritzer KL, Schalet BD, et al. PROMIS((R))-29 v2.0 profile physical and mental health summary scores. Qual Life Res. 2018;27(7):1885–1891.
  • Moorer P, Suurmeije TP, Foets M, et al. Psychometric properties of the RAND-36 among three chronic diseases (multiple sclerosis, rheumatic diseases and COPD) in The Netherlands. Qual Life Res. 2001;10(7):637–645.
  • VanderZee KI, Sanderman R, Heyink JW, et al. Psychometric qualities of the RAND 36-Item health survey 1.0: a multidimensional measure of general health status. Int J Behav Med. 1996;3(2):104–122.
  • Stenton C. The MRC Breathlessness Scale. Occup Med. 2008;58(3):226–227.
  • Fletcher CM, Elmes PC, Fairbairn AS, et al. The significance of respiratory symptoms and the diagnosis of chronic bronchitis in a working population. Br Med J. 1959;2(5147):257–266.
  • Hesselstrand R, Nilsson JA, Sandqvist G. Psychometric properties of the Swedish version of the Scleroderma Health Assessment Questionnaire and the Cochin Hand Function Scale in patients with systemic sclerosis. Scand J Rheumatol. 2013;42(4):317–324.
  • Ekdahl C, Eberhardt K, Andersson SI, et al. Assessing disability in patients with rheumatoid arthritis. Use of a Swedish version of the Stanford Health Assessment Questionnaire. Scand J Rheumatol. 1988;17(4):263–271.
  • Terwee CB, Bot SD, de Boer MR, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol. 2007;60(1):34–42.
  • Mokkink LB, Prinsen CAC, Patrick DL, et al. COSMIN study design checklist for patient-reported outcome measurement instruments. Amsterdam; 2019. Available from: www.cosmin.nl
  • Cicchetti DV, Allison T. A new procedure for assessing reliability of scoring EEG sleep recordings. Am J EEG Technol. 1971;11(3):101–110.
  • Vanbelle S. A new interpretation of the weighted kappa coefficients. Psychometrika. 2016;81(2):399–410.
  • Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics. 1977;33(1):159–174.
  • McHorney CA, Tarlov AR. Individual-patient monitoring in clinical practice: are available health status surveys adequate? Qual Life Res. 1995;4(4):293–307.
  • Cohen J. Statistical power analysis for behavioral sciences. 2nd ed. Hillsdale (NJ): Lawrence Erlbaum Associates; 1988.
  • van Balen EC, Haverman L, Hassan S, et al. Validation of PROMIS profile-29 in adults with hemophilia in The Netherlands. J Thromb Haemost. 2021;19(11):2687–2701.
  • de Vet HCW, Terwee CB, Mokkink LB, et al. Measurement in medicine: a practical guide. Cambridge: Cambridge University Press; 2011.
  • Rothrock NE, Hays RD, Spritzer K, et al. Relative to the general US population, chronic diseases are associated with poorer health-related quality of life as measured by the Patient-Reported Outcomes Measurement Information System (PROMIS). J Clin Epidemiol. 2010;63(11):1195–1204.
  • Hinchcliff ME, Beaumont JL, Carns MA, et al. Longitudinal evaluation of PROMIS-29 and FACIT-Dyspnea short forms in systemic sclerosis. J Rheumatol. 2015;42(1):64–72.
  • Yount SE, Beaumont JL, Chen SY, et al. Health-related quality of life in patients with idiopathic pulmonary fibrosis. Lung. 2016;194(2):227–234.
  • Lai JS, Beaumont JL, Jensen SE, et al. An evaluation of health-related quality of life in patients with systemic lupus erythematosus using PROMIS and Neuro-QoL. Clin Rheumatol. 2017;36(3):555–562.
  • Tang E, Ekundayo O, Peipert JD, et al. Validation of the Patient-Reported Outcomes Measurement Information System (PROMIS)-57 and -29 item short forms among kidney transplant recipients. Qual Life Res. 2019;28(3):815–827.
  • Rawang P, Janwantanakul P, Correia H, et al. Cross-cultural adaptation, reliability, and construct validity of the Thai version of the Patient-Reported Outcomes Measurement Information System-29 in individuals with chronic low back pain. Qual Life Res. 2020;29(3):793–803.
  • Choi SW, Reise SP, Pilkonis PA, et al. Efficiency of static and computer adaptive short forms compared to full-length measures of depressive symptoms. Qual Life Res. 2010;19(1):125–136.
  • Stucky BD, Edelen MO, Sherbourne CD, et al. Developing an item bank and short forms that assess the impact of asthma on quality of life. Respir Med. 2014;108(2):252–263.
  • Cella D, Choi SW, Condon DM, et al. PROMIS((R)) adult health profiles: efficient short-form measures of seven health domains. Value Health. 2019;22(5):537–544.
  • D'Angelo WA, Fries JF, Masi AT, et al. Pathologic observations in systemic sclerosis (scleroderma). A study of fifty-eight autopsy cases and fifty-eight matched controls. Am J Med. 1969;46(3):428–440.
  • Sandqvist G, Scheja A, Eklund M. Working ability in relation to disease severity, everyday occupations and well-being in women with limited systemic sclerosis. Rheumatology. 2008;47(11):1708–1711.
  • Morrisroe K, Huq M, Stevens W, et al. Determinants of unemployment amongst Australian systemic sclerosis patients: results from a multicentre cohort study. Clin Exp Rheumatol. 2016;34 Suppl. 100(5):79–84.
  • Pope JE, Bellamy N. Sample size calculations in scleroderma: a rational approach to choosing outcome measurements in scleroderma trials. Clin Invest Med. 1995;18(1):1–10.
  • Revicki DA, Kawata AK, Harnam N, et al. Predicting EuroQol (EQ-5D) scores from the Patient-Reported Outcomes Measurement Information System (PROMIS) global items and domain item banks in a United States sample. Qual Life Res. 2009;18(6):783–791.
  • Cella D, Gershon R, Lai JS, et al. The future of outcomes measurement: item banking, tailored short-forms, and computerized adaptive assessment. Qual Life Res. 2007;16(Suppl. 1):133–141.
  • Khanna D, Maranian P, Rothrock N, et al. Feasibility and construct validity of PROMIS and "legacy" instruments in an academic scleroderma clinic. Value Health. 2012;15(1):128–134.